James A Hamp, MD | |
1625 Maple Ln, Suite 2, Ashland, WI 54806-3768 | |
(715) 682-9311 | |
(715) 682-2486 |
Full Name | James A Hamp |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 1625 Maple Ln, Ashland, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740271071 | NPI | - | NPPES |
30282700 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 22384 (Wisconsin) | Primary |
207YX0602X | Otolaryngology - Otolaryngic Allergy | 22384 (Wisconsin) | Secondary |
Mailing Address | Practice Location Address |
---|---|
James A Hamp, MD 1625 Maple Ln, Suite 2, Ashland, WI 54806-3768 Ph: (715) 682-9311 | James A Hamp, MD 1625 Maple Ln, Suite 2, Ashland, WI 54806-3768 Ph: (715) 682-9311 |
News Archive
New research published by University of Utah S.J. Quinney College of Law Professor Jorge Contreras in Science this week explores the current state of sharing resources in the biomedical research field and whether the fragmentation of property ownership can stifle research progress, instead of advancing it.
Significant human and animal pathogens remain major scourges to human health. Recent devastating Ebola virus disease outbreak in West Africa underscores the importance of understanding the biology of replication and response of host cells to infection by these pathogens.
Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced today the sale of its AttriusTM PET scanner to Manhattan based, Gramercy Cardiac Diagnostic Services, owned by prominent New York City cardiologist, Dr. Peter Rentrop.
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
› Verified 2 days ago